Clinical trial
Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products
NCT07424157 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products
- Lead sponsor
- Seattle Children's Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 15, 2026
- Completion date
- March 31, 2041
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
car t cell, car t cell therapy